ASSURA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.1 GBX | -0.58% |
|
+1.48% | -14.59% |
| May. 31 | Disaster averted |  |
| May. 31 | ANALYST RECOMMENDATIONS : Humana, Netapp, Dell, Qualcomm, Paypal... | |
| Sales 2025 * | 155M 197M | Sales 2026 * | 159M 202M | Capitalization | 1.23B 1.57B |
|---|---|---|---|---|---|
| Net income 2025 * | 160M 204M | Net income 2026 * | 156M 199M | EV / Sales 2025 * | 15.8 x |
| Net Debt 2025 * | 1.21B 1.54B | Net Debt 2026 * | 1.25B 1.59B | EV / Sales 2026 * | 15.6 x |
| P/E ratio 2025 * |
9.56
x | P/E ratio 2026 * |
8.74
x | Employees | 84 |
| Yield 2025 * |
8.14% | Yield 2026 * |
8.32% | Free-Float | 99.75% |
More Fundamentals
* Assessed data
More news
Latest transcript on Assura Plc
More news
| 1 day | -0.58% | ||
| 1 week | +1.48% | ||
| 1 month | +0.49% | ||
| 3 months | -2.70% | ||
| 6 months | -9.23% | ||
| Current year | -14.59% |
1 week
37.54
41.82
1 month
37.5443.86
Current year
37.5449.04
1 year
37.5450.75
3 years
37.5480.60
5 years
37.5488.00
10 years
37.5488.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 12-12-31 |
Jayne Cottam
DFI | Director of Finance/CFO | 50 | 17-08-03 |
Joanne Cullen
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| 53 | - | ||
Jonathan Davies
BRD | Director/Board Member | 62 | 18-05-31 |
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 12-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 133 M€ | +3.99% | ||
| 0.03% | 746 M€ | -.--% | - | |
| 0.02% | 11 M€ | +5.74% | - | |
| 0.02% | 197 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 41.1 | -0.58% | 18,815,010 |
| 24-05-30 | 41.34 | +2.38% | 31,669,660 |
| 24-05-29 | 40.38 | +0.55% | 4,793,112 |
| 24-05-28 | 40.16 | -0.84% | 8,920,593 |
| 24-05-24 | 40.5 | +0.80% | 10,978,630 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotes
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. The Company owns and manages a portfolio of about 612 properties. The Companyâs subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, Assura Primary Care Properties Ltd, Assura Trellech Ltd, and others.
Sector
Specialized REITs
Calendar
2024-06-05
- Ex-dividend day for optional dividend
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
0.411
GBP
Average target price
0.496
GBP
Spread / Average Target
+20.68%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.59% | 1.56B | |
| +14.97% | 61.99B | |
| +0.84% | 20.31B | |
| +0.51% | 14.01B | |
| +5.45% | 7.99B | |
| -5.80% | 6.14B | |
| +14.32% | 3.63B | |
| +2.24% | 3.38B | |
| +9.16% | 3.22B | |
| -6.13% | 3.08B |
- Stock Market
- Equities
- AGR Stock
